首页> 外文期刊>Analytical chemistry >Reagentless Measurement of Aminoglycoside Antibiotics in Blood Serum via an Electrochemical, Ribonucleic Acid Aptamer-Based Biosensor
【24h】

Reagentless Measurement of Aminoglycoside Antibiotics in Blood Serum via an Electrochemical, Ribonucleic Acid Aptamer-Based Biosensor

机译:通过基于核糖核酸适配体的电化学生物传感器对血清中的氨基糖苷类抗生素进行无试剂检测

获取原文
获取原文并翻译 | 示例
       

摘要

Biosensors built using ribonucleic acid (RNA) aptamers show promise as tools for point-of-care medical diagnostics, but they remain vulnerable to nuclease degradation when deployed in clinical samples. To explore methods for protecting RNA-based biosensors from such degradation we have constructed and characterized an electrochemical, aptamer-based sensor for the detection of aminoglycosidic antibiotics. We find that while this sensor achieves low micromolar detection limits and subminute equilibration times when challenged in buffer, it deteriorates rapidly when immersed directly in blood serum. In order to circumvent this problem, we have developed and tested sensors employing modified versions of the same aptamer. Our first effort to this end entailed the methylation of all of the 2'-hydroxyl groups outside of the aptamer's antibiotic binding pocket. However, while devices employing this modified aptamer are as sensitive as those employing an unmodified parent, the modification fails to confer greater stability when the sensor is challenged directly in blood serum. As a second potentially naive alternative, we replaced the RNA bases in the aptamer with their more degradation-resistant deoxyribonucleic acid (DNA) equivalents. Surprisingly and unlike control DNA-stem loops employing other sequences, this DNA aptamer retains the ability to bind aminoglycosides, albeit with poorer affinity than the parent RNA aptamer. Unfortunately, however, while sensors fabricated using this DNA aptamer are stable in blood serum, its lower affinity pushes their detection limits above the therapeutically relevant range. Finally, we find that ultrafiltration through a low-molecular-weight-cutoff spin column rapidly and efficiently removes the relevant nucleases from serum samples spiked with gentamicin, allowing the convenient detection of this aminoglycoside at clinically relevant concentrations using the original RNA-based sensor.
机译:使用核糖核酸(RNA)适体构建的生物传感器显示出有望成为即时医疗诊断的工具,但是当部署在临床样品中时,它们仍然容易受到核酸酶降解的影响。为了探索保护基于RNA的生物传感器免受此类降解的方法,我们构建并表征了用于检测氨基糖苷类抗生素的电化学,基于适体的传感器。我们发现,虽然该传感器在缓冲液中挑战时可达到较低的微摩尔检测极限和亚微分的平衡时间,但当直接浸入血清中时会迅速变质。为了解决这个问题,我们已经开发并测试了采用同一适体修改版的传感器。为此,我们的第一项努力是在适体的抗生素结合口袋之外将所有2'-羟基甲基化。然而,尽管使用这种修饰的适体的装置与使用未修饰的亲本的装置一样敏感,但是当直接在血清中挑战传感器时,修饰不能赋予更大的稳定性。作为第二种潜在的幼稚替代方法,我们用适量的抗降解性更高的脱氧核糖核酸(DNA)等效物代替了适体中的RNA碱基。出乎意料的是,与采用其他序列的对照DNA-茎环不同,该DNA适体保留了结合氨基糖苷的能力,尽管其亲和力比亲本RNA适体差。然而,不幸的是,尽管使用这种DNA适体制备的传感器在血清中稳定,但其较低的亲和力使它们的检测极限超过了治疗相关范围。最后,我们发现通过低分子量截留离心柱的超滤可快速有效地从庆大霉素加标的血清样品中去除相关的核酸酶,从而可以使用原始的基于RNA的传感器方便地检测临床相关浓度的这种氨基糖苷。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号